AstraZeneca Sees 27% Q2 Profit Surge Driven by Record US Market Growth
British pharmaceutical major AstraZeneca announced on Tuesday a 27% rise in net profit for the second quarter of the year, buoyed by exceptional performance in the United States — its key growth market. According to the company’s Q2 earnings statement, profit after tax reached $2.45 billion for the three months ending 30 June, a significant […]
Read more

